Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

OKYO Pharma

Youtube Subscribe

...

Ticker: OKYO

Sector: Biotechnology

OKYO Pharma Limited engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain. Its lead preclinical product candidate is OK-101 for the treatment of dry eye disease. OK-201 is a bov.
...
...
Extended Summary

OKYO Pharma

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

Related Results

...
February 21, 2024 17:07 (London Time)

OKYO Pharma

OKYO Pharma has a 12-month low of $0.92 and a 12 month high of $7.00. OK-101 is a non-opioid analgesic designed to mitigate neuropathic corneal pain…
Sector: Biotechnology
Ticker: OKYO
Sentiment: -0.6908
MarketCap: 48,524,633.0
High: 1.47 Low: 1.39

Open: 1.45 Close: 1.46 Change: 0.01

Read more →
...
August 19, 2023 3:53 (London Time)

OKYO Pharma

OKYO Pharma Limited is developing OK-101 to treat dry eye disease (“DED”) to address the significant unmet need in this multi-billion-dollar market.…
Sector: Biotechnology
Ticker: OKYO
Sentiment: 0.3818
MarketCap: 39,607,574.0
High: 1.7 Low: 1.38

Open: 1.5 Close: 1.63 Change: 0.13

Read more →
...
October 12, 2023 4:21 (London Time)

OKYO Pharma

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic…
Sector: Biotechnology
Ticker: OKYO
Sentiment: -0.5574
MarketCap: 52,206,896.0
High: 1.83 Low: 1.71

Open: 1.83 Close: 1.74 Change: -0.09

Read more →
...
July 09, 2023 21:32 (London Time)

OKYO Pharma

OKYO Pharma Ltd. has 8.41 million shares outstanding. The beta is -2.97, so the companys price volatility has been lower than the market average. Th…
Sector: Biotechnology
Ticker: OKYO
Sentiment: 0.6481
MarketCap: 27,563,907.0
High: 1.17 Low: 1.08

Open: 1.11 Close: 1.08 Change: -0.03

Read more →
Search
Happening Now
Categories